[Improved prognosis in Wilms' tumor due to adjuvant combination drug therapy]

Standard

[Improved prognosis in Wilms' tumor due to adjuvant combination drug therapy]. / Haas, R J; Helmig, F J; Hausner, H; Eife, R; Devens, K; Janka-Schaub, Gritta; Helmig, M; Lampert, F.

in: ONKOLOGIE, Jahrgang 5, Nr. 2, 2, 1982, S. 60-66.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Haas, RJ, Helmig, FJ, Hausner, H, Eife, R, Devens, K, Janka-Schaub, G, Helmig, M & Lampert, F 1982, '[Improved prognosis in Wilms' tumor due to adjuvant combination drug therapy]', ONKOLOGIE, Jg. 5, Nr. 2, 2, S. 60-66. <http://www.ncbi.nlm.nih.gov/pubmed/6285242?dopt=Citation>

APA

Haas, R. J., Helmig, F. J., Hausner, H., Eife, R., Devens, K., Janka-Schaub, G., Helmig, M., & Lampert, F. (1982). [Improved prognosis in Wilms' tumor due to adjuvant combination drug therapy]. ONKOLOGIE, 5(2), 60-66. [2]. http://www.ncbi.nlm.nih.gov/pubmed/6285242?dopt=Citation

Vancouver

Haas RJ, Helmig FJ, Hausner H, Eife R, Devens K, Janka-Schaub G et al. [Improved prognosis in Wilms' tumor due to adjuvant combination drug therapy]. ONKOLOGIE. 1982;5(2):60-66. 2.

Bibtex

@article{76059b32363347338d60855c485096df,
title = "[Improved prognosis in Wilms' tumor due to adjuvant combination drug therapy]",
abstract = "78 children with Wilms' tumor stage I--IV diagnosed since 1960 are presented. There were two groups of patients: one group consisting of 35 patients which received adjuvant chemotherapy for 1 year, the other group consisting of 43 patients which received no chemotherapy. Surgical excision and irradiation was identical in both groups. The prognosis was greatly improved by adjuvant chemotherapy: 4-year survival rates increased from 25 to 69%. Late side effects from radiation and chemotherapy were noted: 15/78 patients suffered from scoliosis and all patients treated by chemotherapy had a decreased lymphotoxin activity over years. The following factors appear to be related to prognosis: the extent of disease in patients determined by better techniques, histopathology of the tumor, and the nature of treatment.",
author = "Haas, {R J} and Helmig, {F J} and H Hausner and R Eife and K Devens and Gritta Janka-Schaub and M Helmig and F Lampert",
year = "1982",
language = "Deutsch",
volume = "5",
pages = "60--66",
journal = "ONKOLOGIE",
issn = "0378-584X",
publisher = "S. Karger AG",
number = "2",

}

RIS

TY - JOUR

T1 - [Improved prognosis in Wilms' tumor due to adjuvant combination drug therapy]

AU - Haas, R J

AU - Helmig, F J

AU - Hausner, H

AU - Eife, R

AU - Devens, K

AU - Janka-Schaub, Gritta

AU - Helmig, M

AU - Lampert, F

PY - 1982

Y1 - 1982

N2 - 78 children with Wilms' tumor stage I--IV diagnosed since 1960 are presented. There were two groups of patients: one group consisting of 35 patients which received adjuvant chemotherapy for 1 year, the other group consisting of 43 patients which received no chemotherapy. Surgical excision and irradiation was identical in both groups. The prognosis was greatly improved by adjuvant chemotherapy: 4-year survival rates increased from 25 to 69%. Late side effects from radiation and chemotherapy were noted: 15/78 patients suffered from scoliosis and all patients treated by chemotherapy had a decreased lymphotoxin activity over years. The following factors appear to be related to prognosis: the extent of disease in patients determined by better techniques, histopathology of the tumor, and the nature of treatment.

AB - 78 children with Wilms' tumor stage I--IV diagnosed since 1960 are presented. There were two groups of patients: one group consisting of 35 patients which received adjuvant chemotherapy for 1 year, the other group consisting of 43 patients which received no chemotherapy. Surgical excision and irradiation was identical in both groups. The prognosis was greatly improved by adjuvant chemotherapy: 4-year survival rates increased from 25 to 69%. Late side effects from radiation and chemotherapy were noted: 15/78 patients suffered from scoliosis and all patients treated by chemotherapy had a decreased lymphotoxin activity over years. The following factors appear to be related to prognosis: the extent of disease in patients determined by better techniques, histopathology of the tumor, and the nature of treatment.

M3 - SCORING: Zeitschriftenaufsatz

VL - 5

SP - 60

EP - 66

JO - ONKOLOGIE

JF - ONKOLOGIE

SN - 0378-584X

IS - 2

M1 - 2

ER -